We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

WONDFO

Wondfo is a high-tech biological company focusing providing professional products and services for rapid diagnosis an... read more Featured Products: More products

Download Mobile App





Wondfo Presents Advanced Solutions in CLIA Testing and Blood Gas Analysis

By LabMedica International staff writers
Posted on 13 Nov 2024
Print article
Image: Wondfo’s innovative products and diagnostic solutions can be experienced at MEDICA 2024 (Photo courtesy of Wondfo)
Image: Wondfo’s innovative products and diagnostic solutions can be experienced at MEDICA 2024 (Photo courtesy of Wondfo)

Wondfo (Guangzhou, China) is presenting a variety of new products at MEDICA 2024, including its new FC-2100 fully automatic chemiluminescence immunoassay analyzer, the Finecare FIA Meter X1 and X2 fluorescence immunoassay analyzer, and the Ucare-6000 automatic blood gas analyzer.

With its precision and efficiency, FC-2100 is attracting a lot of attention at this year’s MEDICA. As a desktop fully-automatic chemiluminescence immunoassay analyzer, it only covers 0.64 sqm, which is more flexible and convenient and can be installed and placed in almost all laboratory operating tables. It has a test speed of up to 200T/hour and shows the first result within 12 minutes. Wondfo’s new immunofluorescence platform, Finecare X Series-FS-1000 & FS-2000, is accurate, efficient, and easy to use. Its motto is “One-Step Operation, Always One Step Ahead.” The X series supports whole blood sample testing. Taking into account the different needs of labs, this new platform offers single-channel (X1) and multi-channels (X2) for options. Its hs-cTnI sensitivity of 20pg/ml enables labs to provide more effective support for acute and critical diseases. Wondfo is also showcasing its colloidal gold Strep A Test Kit which is available for both self-testing and professional use. The Wondfo One Step Strep A Swab Test is a rapid chromatographic immunoassay for the qualitative detection of group A streptococcal antigen from throat swab specimens and is intended for use as an aid in the diagnosis of group A streptococcal infection.

Visitors to the Wondfo booth are also showing great interest in the Ucare-6000 automatic blood gas analyzer which enjoys efficiency, flexibility, and simplified operation. The integration of the electrode cartridge with the reagent bag simplifies the testing operation to one-step sample loading and reduces the cost of individual test cartridges. The Ucare-6000 features an expansive menu comprising 34 parameters of blood gas, electrolytes, metabolites, and Hct, and features a built-in battery that allows 6-hour standby. In addition, Wondfo is highlighting the PA-3600 fully automated IHC staining system that has been independently developed by the company. The PA-3600 is suitable for a wide range of sample types, and can automatically complete the entire process of immunohistochemical staining from baking to re-staining. Since its official launch in 2021, it has been widely used in hospitals, research institutes, ICLs (Independent Clinical Laboratory), pharmaceutical CROs, and other organizations, and has gained recognition for its excellent performance and quality.

Related Links:
Wondfo

Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Food Allergens Assay Kit
Allerquant 14G A
New
Adenovirus Detection Kit
REALQUALITY RQ-ADENO

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Immunology

view channel
Image: An immune response is initiated when an antigen-presenting cell (pink) presents foreign material to a T-cell (blue) (Photo courtesy of JAX)

Advanced Imaging Method Maps Immune Cell Connections to Predict Cancer Patients Survival

A growing tumor is influenced not only by the tumor cells themselves but also by the surrounding tissue, which alters its biology. Immune cells communicate by transferring vital signaling proteins to their... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: SCOPE IO has shown promise in predicting immunotherapy response in rare cancer patients (Photo courtesy of Lunit)

AI-Powered Whole-Slide Image Analyzer Predicts Immunotherapy Response for Rare Cancer Patients

Immunotherapy, especially immune checkpoint inhibitors like pembrolizumab, has become a groundbreaking treatment for cancer patients. However, not all patients respond the same way to this therapy, and... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.